Total Payments
$736,569
2024 Payments
$193,459
Companies
42
Transactions
700
Medicare Patients
4,168
Medicare Billing
$544,718
Payment Breakdown by Category
Other$473,745 (64.3%)
Consulting$174,643 (23.7%)
Travel$38,786 (5.3%)
Food & Beverage$29,874 (4.1%)
Royalty/License$19,418 (2.6%)
Education$102.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $370,290 | 142 | 50.3% |
| Consulting Fee | $174,643 | 66 | 23.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $61,725 | 13 | 8.4% |
| Honoraria | $41,730 | 13 | 5.7% |
| Travel and Lodging | $38,786 | 128 | 5.3% |
| Food and Beverage | $29,874 | 334 | 4.1% |
| Royalty or License | $19,418 | 2 | 2.6% |
| Education | $102.50 | 1 | 0.0% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
General
$736,569
699 transactions
Ownership
$0
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $169,953 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $150,200 | 132 | $0 (2024) |
| Abbott Laboratories | $130,368 | 169 | $0 (2024) |
| ShockWave Medical, Inc | $72,609 | 25 | $0 (2024) |
| Amgen Inc. | $71,022 | 71 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $36,488 | 33 | $0 (2024) |
| Philips Electronics North America Corporation | $23,598 | 37 | $0 (2023) |
| Medtronic Vascular, Inc. | $19,765 | 6 | $0 (2020) |
| Philips North America LLC | $11,182 | 14 | $0 (2024) |
| Chiesi USA, Inc. | $10,369 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193,459 | 203 | Amgen Inc. ($50,534) |
| 2023 | $183,824 | 150 | Novo Nordisk Inc ($53,247) |
| 2022 | $182,892 | 141 | Novo Nordisk Inc ($79,725) |
| 2021 | $115,667 | 93 | Abbott Laboratories ($50,689) |
| 2020 | $25,082 | 36 | Abbott Laboratories ($23,202) |
| 2019 | $24,879 | 38 | Medtronic Vascular, Inc. ($12,658) |
| 2018 | $8,675 | 19 | Medtronic Vascular, Inc. ($6,921) |
| 2017 | $2,092 | 20 | BIOTRONIK INC. ($942.88) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $166.48 | General |
| Category: Vascular | ||||||
| 12/20/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $144.70 | General |
| 12/20/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Vascular | ||||||
| 12/20/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Vascular | ||||||
| 12/17/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $129.66 | General |
| Category: AVVIGO_IC | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $86.62 | General |
| Category: AVVIGO_IC | ||||||
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $165.86 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Cardiovascular | ||||||
| 12/08/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $120.55 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $34.02 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 11/29/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: Vascular | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,037.50 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Vascular | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $119.31 | General |
| Category: Obesity | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,487.50 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $118.72 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Travel and Lodging | In-kind items and services | $90.99 | General |
| Category: Obesity | ||||||
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Abbott Laboratories | PERCLOSE PROSTYLE (Device) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,104 | 1,359 | $566,647 | $145,066 |
| 2022 | 28 | 1,318 | 1,633 | $701,381 | $179,693 |
| 2021 | 23 | 1,251 | 1,526 | $587,475 | $155,021 |
| 2020 | 15 | 495 | 618 | $268,942 | $64,939 |
Total Patients
4,168
Total Services
5,136
Medicare Billing
$544,718
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 183 | 220 | $132,066 | $33,637 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 148 | $65,416 | $15,582 | 23.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 129 | $52,374 | $14,191 | 27.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 25 | $53,975 | $13,818 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 153 | $41,310 | $11,040 | 26.7% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 31 | 31 | $41,478 | $10,387 | 25.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 35 | $36,855 | $8,259 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $25,212 | $6,905 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $17,730 | $4,797 | 27.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 41 | 79 | $13,667 | $3,680 | 26.9% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $12,232 | $3,352 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 43 | $13,459 | $3,278 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 22 | $10,418 | $2,936 | 28.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 29 | 31 | $10,571 | $2,897 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 18 | $8,046 | $2,203 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $8,685 | $2,153 | 24.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 139 | 144 | $7,488 | $1,764 | 23.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 50 | 54 | $4,212 | $1,117 | 26.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 71 | 76 | $3,420 | $937.08 | 27.4% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 13 | 13 | $3,380 | $924.56 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $3,168 | $812.55 | 25.6% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 29 | 33 | $1,485 | $398.24 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 127 | 167 | $105,878 | $26,581 | 25.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 30 | 41 | $94,669 | $24,911 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 199 | $88,754 | $22,979 | 25.9% |
About Dr. Evan Shlofmitz, DO
Dr. Evan Shlofmitz, DO is a Interventional Cardiology healthcare provider based in Roslyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2010. The National Provider Identifier (NPI) number assigned to this provider is 1639494479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Shlofmitz, DO has received a total of $736,569 in payments from pharmaceutical and medical device companies, with $193,459 received in 2024. These payments were reported across 700 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($370,290).
As a Medicare-enrolled provider, Shlofmitz has provided services to 4,168 Medicare beneficiaries, totaling 5,136 services with total Medicare billing of $544,718. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Roslyn, NY
- Active Since 04/05/2010
- Last Updated 06/10/2020
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1639494479
Products in Payments
- XARELTO (Drug) $150,200
- Ozempic (Drug) $81,666
- Repatha (Biological) $70,177
- Dragonfly OCT (Device) $50,901
- Inpefa (Drug) $36,488
- Xience V coronary stent system (Device) $33,516
- (9520) IGT Devices Undivided (Device) $33,189
- OPTIS (Device) $30,472
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $29,035
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $27,320
- VenaSeal (Device) $19,418
- Rybelsus (Drug) $17,215
- Vascular Lithotripsy (Device) $16,254
- Wegovy (Drug) $13,138
- KENGREAL (Drug) $10,369
- Diamondback Coronary (Device) $6,003
- HD-IVUS (Device) $5,397
- FARXIGA (Drug) $4,745
- XIENCE V (Device) $3,719
- SavvyWire (Device) $2,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Roslyn
David Cohen, M.d, M.D
Interventional Cardiology — Payments: $430,699
Interventional Cardiology $430,699
Richard Shlofmitz, M.d, M.D
Interventional Cardiology — Payments: $83,621
Interventional Cardiology $83,621
Dr. Andrew Berke, M.d, M.D
Interventional Cardiology — Payments: $9,390
Interventional Cardiology $9,390
Mr. Alfred Randall, Md, MD
Interventional Cardiology
Interventional Cardiology
Dr. Harminder Gill, Bmbch, BMBCH
Interventional Cardiology
Interventional Cardiology